Alzheimer’s Treatment Needs More Than Amyloid TL;DR: A 2026 review in Science China Life Sciences argues that amyloid-beta antibodies such as lecanemab and donanemab are important progress, but Alzheimer’s treatment cannot stop at amyloid. The disease also involves tau tangles, genetics, aging biology, immune changes, vascular and metabolic health, and systemic conditions that shape whether …
Broken Blood Vessels May Drive Alzheimer’s Decline TL;DR: A new study reveals that impaired cerebrovascular function—the brain’s ability to regulate blood flow—correlates strongly with Alzheimer’s symptoms, offering a potential non-invasive way to detect early cognitive decline. Alzheimer’s disease has long been framed as a problem of toxic protein accumulation: amyloid plaques and tau tangles strangling …
How the Brain Hijacks Balance Control in Parkinson’s TL;DR: When older adults face large balance challenges, their brains shift from relying on quick brainstem reflexes to slower cortical circuits—a shift that happens even in Parkinson’s disease, revealing a mechanistic window into age-related balance loss. Balance isn’t automatic. When you stumble forward or feel the ground …
How Lecanemab Clears Brain Amyloid: The Microglia Key TL;DR: Lecanemab, the first Alzheimer’s antibody to slow cognitive decline, works by activating immune cells called microglia through a specific immune signaling pathway, with the molecule SPP1/osteopontin playing a critical role in triggering the brain’s own cleanup machinery. When lecanemab was approved by the FDA, it sparked …
Chlorpyrifos Linked to 2.5x Higher Parkinson’s Risk TL;DR: A pesticide sprayed on US crops decades ago more than doubles your risk of Parkinson’s disease, and new research shows exactly how it damages dopamine neurons. You probably never heard of chlorpyrifos, but your neighborhood may have been sprayed with it. This common agricultural insecticide was applied …
The Death Complex Fueling Alzheimer’s (And How to Stop It) TL;DR: Researchers discovered a toxic interaction between two brain proteins—NMDAR and TRPM4—that drives neurodegeneration in Alzheimer’s disease, and a small molecule called FP802 that blocks this “death complex” and prevents cognitive decline in mice. Alzheimer’s disease devastates the brain through multiple pathways, but the exact …
Dirty Air, Fragile Brain: PM2.5’s Direct Link to Alzheimer’s TL;DR: A massive study of 27.8 million Medicare beneficiaries found that exposure to fine air pollution (PM2.5) increases Alzheimer’s risk by 8.5% per unit increase—and this effect operates largely through direct brain damage, not through common health conditions like stroke or depression. The conventional thinking about …
Microplastics and Brain Damage: The Hidden Link TL;DR: Microplastics circulating in your blood may accelerate Alzheimer’s and Parkinson’s disease through six shared pathways—including blood-brain barrier breakdown, chronic inflammation, and oxidative stress. You probably know plastic pollution is everywhere. Less obvious: tiny plastic fragments are crossing into your brain, accumulating in brain tissue, and potentially triggering …
The Broken Repair Crew: How TDP43 Sabotages Genome Stability TL;DR: TDP43, the protein that misfires in ALS and FTD, secretly controls DNA repair genes—and when it breaks, mutations pile up in neurons, potentially explaining both neurodegeneration and the cancer link in these diseases. A protein known for its role in neurodegenerative disease has a hidden …
Blood Test Predicts Alzheimer’s 3-4 Years Early TL;DR: A blood test measuring phosphorylated tau-217 can predict when cognitively normal people will develop Alzheimer’s symptoms with a 3.0-3.7 year margin of error, potentially transforming how researchers identify candidates for preventive clinical trials. For decades, Alzheimer’s disease remained invisible until symptoms emerged. Brain scans could show amyloid …
